Benchmark Reiterates Buy on Beauty Health, Maintains $23 Price Target
Benchmark analyst Bruce Jackson reiterates Beauty Health (NASDAQ:SKIN) with a Buy and maintains $23 price target.
DA Davidson Maintains Buy on Beauty Health, Raises Price Target to $35
DA Davidson analyst Linda Bolton Weiser maintains Beauty Health (NASDAQ:SKIN) with a Buy and raises the price target from $32 to $35.
Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.
Why Beauty Health Shares Are Trading Higher Today
Beauty Health (NASDAQ: SKIN) shares are trading higher on Tuesday after the company reported better-than-expected Q4 results.
Beauty Health Launches Skin Renewal Booster In Partnership With Hungarian Skincare Brand Omorovicza
The Beauty Health Co (NASDAQ:SKIN) stated its global launch of a new booster co-created with Hungarian skincare brand Omorovicza. The booster leverages…
BeautyHealth’s Hydrafacial and Prestige Skincare Brand Omorovicza Global Launches Advanced Skin Renewal Booster
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announces the global launch of a new booster co-created with Hungarian skincare brand Omorovicza. The booster, available immediately to
Cowen & Co. Maintains Outperform on Beauty Health, Lowers Price Target to $15
Cowen & Co. analyst Oliver Chen maintains Beauty Health (NASDAQ:SKIN) with a Outperform and lowers the price target from $20 to $15.
Top 5 Defensive Stocks That May Fall Off A Cliff
The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies.
What 6 Analyst Ratings Have To Say About Beauty Health
Within the last quarter, Beauty Health (NASDAQ:SKIN) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
Goldman Sachs Maintains Buy on Beauty Health, Lowers Price Target to $19
Goldman Sachs analyst Amit Hazan maintains Beauty Health (NASDAQ:SKIN) with a Buy and lowers the price target from $22 to $19.